Menu
Search
|

Menu

Close
X

Genomma Lab Internacional SAB de CV LABB.MX (Mexico Stock Exchange)

15.51 MXN
+0.22 (+1.44%)
As of 3:59 PM EDT
chart
Previous Close 15.29
Open 15.32
Volume 4,816,100
3m Avg Volume 3,154,989
Today’s High 15.95
Today’s Low 15.12
52 Week High 25.08
52 Week Low 15.12
Shares Outstanding (mil) 1,048.73
Market Capitalization (mil) 16,508.95
Forward P/E 12.27
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.79 Mean rating from 14 analysts

KEY STATS

Revenue (mm, MXN)
FY18
3,025
FY17
12,078
FY16
11,316
FY15
11,042
EPS (MXN)
FY18
0.361
FY17
1.302
FY16
-1.603
FY15
-1.084
*Note: Units in Millions of Mexican Pesos
**Note: Units in Mexican Pesos

KEY RATIOS

Price to Earnings (TTM)
vs sector
12.27
33.05
Price to Sales (TTM)
vs sector
1.39
8.10
Price to Book (MRQ)
vs sector
2.01
4.20
Price to Cash Flow (TTM)
vs sector
11.93
22.23
Total Debt to Equity (MRQ)
vs sector
85.49
17.32
LT Debt to Equity (MRQ)
vs sector
56.53
13.18
Return on Investment (TTM)
vs sector
11.57
13.17
Return on Equity (TTM)
vs sector
17.48
15.10

EXECUTIVE LEADERSHIP

Rodrigo Alonso Herrera Aspra
Chairman of the Board, Independent Director, Since 2016
Salary: --
Bonus: --
Maximo Juda
Chief Executive Officer, Since 2015
Salary: --
Bonus: --
Antonio Zamora Galland
Executive Vice President, Chief Financial Officer, Since 2015
Salary: --
Bonus: --
Marco Sparvieri
Executive Vice-President of Global Sales, Since 2015
Salary: --
Bonus: --
Alejandro Baston Patino
Vice-President of International and Sales Development, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Edificio Samara
Antonio Dovali Jaime no. 70 Piso
Colonia Santa Fe
MEXICO, D.F.     01210

Phone: +5255.50810000

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

SPONSORED STORIES